NEW MEDICAL USE OF TRIAZINE DERIVATIVES

摘要

Compounds of formula (I) especially where R¹ is an optionally substituted alkyl, aralkyl or heterocyclyl-alkyl group, are shown to have activity as sodium channel blockers or as antifolates. Some novel compounds where R¹ is an aralkyl or heterocyclyl-alkyl are disclosed.